{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:45:47Z","timestamp":1792557947243,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010882","name":"TianJin Education Committee","doi-asserted-by":"publisher","award":["2022KJ154"],"award-info":[{"award-number":["2022KJ154"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015406","name":"Tianjin Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["23ZGCXQY00060"],"award-info":[{"award-number":["23ZGCXQY00060"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.phymed.2025.156686","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T13:39:45Z","timestamp":1743082785000},"page":"156686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Exploration of mechanism of Bufalin and Bufalin derivatives in hepatocellular carcinoma"],"prefix":"10.1016","volume":"141","author":[{"given":"Xinchen","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrun","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-989X","authenticated-orcid":false,"given":"Xiankuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phymed.2025.156686_bib0001","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.livres.2023.11.004","article-title":"Hepatocellular carcinoma recurrence: predictors and management","volume":"7","author":"Abdelhamed","year":"2023","journal-title":"Liver. Res."},{"issue":"2","key":"10.1016\/j.phymed.2025.156686_bib0002","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.annonc.2020.11.011","article-title":"Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1","volume":"32","author":"Andr\u00e9","year":"2021","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.phymed.2025.156686_bib0003","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3390\/molecules26071905","article-title":"Na+\/K+-ATPase revisited: on its mechanism of action, role in cancer, and activity modulation","volume":"26","author":"Bej\u010dek","year":"2021","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0004","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41467-021-25728-8","article-title":"MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I","volume":"12","author":"Br\u00e4gelmann","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phymed.2025.156686_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s43018-021-00218-4","article-title":"The present and future of PI3K inhibitors for cancer therapy","volume":"2","author":"Castel","year":"2021","journal-title":"Nat. Cancer"},{"issue":"7","key":"10.1016\/j.phymed.2025.156686_bib0006","first-page":"660","article-title":"Research progress of targeting hedgehog signaling pathway in the treatment of ovarian cancer","volume":"41","author":"Chen","year":"2021","journal-title":"Henan traditional Chinese medicine"},{"key":"10.1016\/j.phymed.2025.156686_bib0007","series-title":"The Structural Modification of Bufalin and Its Structure-Cytotoxicity Relationship Study","author":"Chen","year":"2013"},{"issue":"10","key":"10.1016\/j.phymed.2025.156686_bib0008","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41416-024-02875-5","article-title":"The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy","volume":"131","author":"Egeland","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"15","key":"10.1016\/j.phymed.2025.156686_bib0009","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1200\/JCO.20.03433","article-title":"Umbralisib, a dual PI3K\u03b4\/CK1\u03b5 inhibitor in patients with relapsed or refractory indolent lymphoma","volume":"39","author":"Fowler","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.156686_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2017.06.003","article-title":"New liver cancer biomarkers: pI3K\/AKT\/mTOR pathway members and eukaryotic translation initiation factors","volume":"83","author":"Golob-Schwarzl","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phymed.2025.156686_bib0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2024.08.004","article-title":"Unveiling the role of PIK3R1 in cancer: a comprehensive review of regulatory signaling and therapeutic implications","author":"Gupta","year":"2024","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0013","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3892\/ijo.2013.1942","article-title":"Bufalin induces G2\/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells","volume":"43","author":"Hsu","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10495-013-0914-7","article-title":"Blocking autophagy enhances the apoptosis effect of Bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation","volume":"19","author":"Hu","year":"2014","journal-title":"Apoptosis."},{"key":"10.1016\/j.phymed.2025.156686_bib0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/OTT.S333233","article-title":"The research progress of Bufalin in the treatment of hepatocellular carcinoma","volume":"15","author":"Jiang","year":"2022","journal-title":"Onco Targets. Ther."},{"issue":"25","key":"10.1016\/j.phymed.2025.156686_bib0016","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/jm0202066","article-title":"QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC\/PRF\/5(1)","volume":"45","author":"Kamano","year":"2002","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0017","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s11033-024-09865-z","article-title":"EGFR mutations and abnormal trafficking in cancers","volume":"51","author":"Kang","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.phymed.2025.156686_bib0018","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s10787-024-01517-9","article-title":"Pharmacological insights and role of Bufalin (bufadienolides) in inflammation modulation: a narrative review","volume":"32","author":"Kaur","year":"2024","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.phymed.2025.156686_bib0019","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.steroids.2016.01.011","article-title":"Synthesis and biological evaluation of bufalin-3-yl nitrogen-containing-carbamate derivatives as anticancer agents","volume":"108","author":"Lei","year":"2016","journal-title":"Steroids."},{"issue":"3","key":"10.1016\/j.phymed.2025.156686_bib0020","first-page":"825","article-title":"Na+\/K+-ATPase \u03b13 mediates sensitivity of hepatocellular carcinoma cells to Bufalin","volume":"25","author":"Li","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0021","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1186\/s12885-024-13168-8","article-title":"EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis","volume":"24","author":"Liu","year":"2024","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.phymed.2025.156686_bib0022","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fitote.2019.03.006","article-title":"Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom","volume":"134","author":"Liu","year":"2019","journal-title":"Fitoterapia"},{"issue":"7","key":"10.1016\/j.phymed.2025.156686_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159789","article-title":"A novel Bufalin derivative exhibited stronger apoptosis-inducing effect than Bufalin in A549 lung cancer cells and lower acute toxicity in mice","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS. One"},{"issue":"11","key":"10.1016\/j.phymed.2025.156686_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000529","article-title":"An efficient strategy for the chemo-enzymatic synthesis of bufalin glycosides with improved water solubility and inhibition against Na+, K+ -ATPase","volume":"17","author":"Liu","year":"2020","journal-title":"Chem. Biodivers."},{"issue":"2","key":"10.1016\/j.phymed.2025.156686_bib0025","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/HM9.0000000000000118","article-title":"Chemical nature of metabolic activation of natural products in traditional Chinese medicines possibly associated with toxicities","volume":"4","author":"Liu","year":"2024","journal-title":"Acupuncture and Herbal Medicine"},{"issue":"5","key":"10.1016\/j.phymed.2025.156686_bib0026","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.steroids.2013.02.007","article-title":"Synthesis and structure-activity relationships study of cytotoxic bufalin 3-nitrogen-containing-ester derivatives","volume":"78","author":"Ma","year":"2013","journal-title":"Steroids."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0027","article-title":"First-line treatment of EGFR-mutated non-small cell lung cancer with brain metastases: a systematic review and meta-analysis","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.phymed.2025.156686_bib0028","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1158\/1078-0432.CCR-17-0725","article-title":"A first-time-in-Human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors","volume":"23","author":"Mateo","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.phymed.2025.156686_bib0029","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1080\/14786419.2020.1741582","article-title":"Two new 19-hydroxy bufadienolides with cytotoxic activity from the skins of Bufo melanosticus","volume":"35","author":"Meng","year":"2021","journal-title":"Nat. Prod. Res."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0030","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3390\/ijms14011370","article-title":"Anticancer effects of Bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy","volume":"14","author":"Miao","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0031","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/2159-8290.CD-20-0553","article-title":"Triplet therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-mutant breast cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid cancers","volume":"11","author":"Pascual","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2025.156686_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106553","article-title":"Biological impact and therapeutic perspective of targeting PI3K\/AKT signaling in hepatocellular carcinoma: promises and challenges","volume":"187","author":"Paskeh","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2025.156686_bib0033","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10107","article-title":"Integrated network pharmacology and molecular docking approaches to reveal the synergistic mechanism of multiple components in Venenum Bufonis for ameliorating heart failure","volume":"8","author":"Ren","year":"2020","journal-title":"PeerJ."},{"issue":"6","key":"10.1016\/j.phymed.2025.156686_bib0034","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"277","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12885-022-09211-1","article-title":"The mixed blessing of AMPK signaling in cancer treatments","volume":"22","author":"Sadria","year":"2022","journal-title":"BMC. Cancer"},{"issue":"4","key":"10.1016\/j.phymed.2025.156686_bib0036","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3892\/ijo.2016.3667","article-title":"Inhibitory effect of Bufalin combined with hedgehog signaling pathway inhibitors on proliferation and invasion and metastasis of liver cancer cells","volume":"49","author":"Sheng","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0037","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1574892816666210201120324","article-title":"Effect of PI3K\/AKT\/mTOR signaling pathway on regulating and controlling the anti-invasion and metastasis of hepatoma cells by Bufalin","volume":"16","author":"Sheng","year":"2021","journal-title":"Recent. Pat. AntiCancer Drug Discov."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0038","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12967-024-05377-3","article-title":"Deciphering the SOX4\/MAPK1 regulatory axis: a phosphoproteomic insight into IQGAP1 phosphorylation and pancreatic cancer progression","volume":"22","author":"Song","year":"2024","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.phymed.2025.156686_bib0039","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/fcp.12306","article-title":"Bufalin, a bufanolide steroid from the parotoid glands of the Chinese toad, suppresses hERG K+ currents expressed in HEK293 cells","volume":"31","author":"Song","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.phymed.2025.156686_bib0040","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines."},{"issue":"5\u20136","key":"10.1016\/j.phymed.2025.156686_bib0041","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10495-023-01930-5","article-title":"Mechanism of Bufalin inhibition of colon cancer liver metastasis by regulating M2-type polarization of Kupffer cells induced by highly metastatic colon cancer cells","volume":"29","author":"Tang","year":"2024","journal-title":"Apoptosis."},{"key":"10.1016\/j.phymed.2025.156686_bib0042","article-title":"Novel stereoselective bufadienolides reveal new insights into the requirements for Na+, K+-ATPase inhibition by cardiotonic steroids","volume":"6","author":"Tang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0043","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1038\/s41598-023-31593-w","article-title":"PIK3CA and PIK3R1 tumor mutational landscape in a pan-cancer patient cohort and its association with pathway activation and treatment efficacy","volume":"13","author":"Tharin","year":"2023","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phymed.2025.156686_bib0044","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1186\/s12885-023-11480-3","article-title":"MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor","volume":"23","author":"Wang","year":"2023","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.phymed.2025.156686_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114587","article-title":"Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK\/mTOR signaling pathway","volume":"186","author":"Wu","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2025.156686_bib0048","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.intimp.2018.08.016","article-title":"BF211, a derivative of Bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6\/JAK2\/STAT3 pathway","volume":"64","author":"Wu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2025.156686_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156130","article-title":"Bufalin induces ferroptosis by modulating the 2,4-dienoyl-CoA reductase (DECR1)-SLC7A11 axis in breast cancer","volume":"135","author":"Wu","year":"2024","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.phymed.2025.156686_bib0049","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/HM9.0000000000000119","article-title":"Safety evaluation of traditional Chinese medicine: new era, new strategy","volume":"4","author":"Xu","year":"2024","journal-title":"Acupuncture and Herbal Medicine"},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s43556-024-00184-0","article-title":"Signaling pathways in liver cancer: pathogenesis and targeted therapy","volume":"5","author":"Xue","year":"2024","journal-title":"Mol. Biomed."},{"issue":"5","key":"10.1016\/j.phymed.2025.156686_bib0051","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41419-021-03780-y","article-title":"Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"1\u20132","key":"10.1016\/j.phymed.2025.156686_bib0052","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsbmb.2004.01.010","article-title":"Novel cytotoxic bufadienolides derived from Bufalin by microbial hydroxylation and their structure-activity relationships","volume":"91","author":"Ye","year":"2004","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.phymed.2025.156686_bib0053","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s13402-020-00546-0","article-title":"Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation","volume":"43","author":"Yu","year":"2020","journal-title":"Cell Oncol. (Dordr)"},{"issue":"5","key":"10.1016\/j.phymed.2025.156686_bib0054","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004297","article-title":"Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma","volume":"10","author":"Yu","year":"2022","journal-title":"J. ImmunOther Cancer"},{"issue":"16","key":"10.1016\/j.phymed.2025.156686_bib0055","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.7150\/jca.44126","article-title":"Research trends on the relationship between microbiota and gastric cancer: a bibliometric analysis from 2000 to 2019","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.phymed.2025.156686_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101005","article-title":"Cell membrane-camouflaged Bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer","volume":"71","author":"Zhang","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.phymed.2025.156686_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155395","article-title":"Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1\/\u03b2-catenin signaling","volume":"126","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.156686_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216657","article-title":"Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer","volume":"587","author":"Zhao","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.phymed.2025.156686_bib0059","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05016-22","article-title":"Traditional Chinese medicine Bufalin inhibits infectious hematopoietic necrosis virus infection in vitro and in vivo","volume":"12","author":"Zhao","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.phymed.2025.156686_bib0060","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1186\/s12967-024-05830-3","article-title":"Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma","volume":"22","author":"Zheng","year":"2024","journal-title":"J. Transl. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325003265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325003265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:48:01Z","timestamp":1762332481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325003265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":60,"alternative-id":["S0944711325003265"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156686","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of mechanism of Bufalin and Bufalin derivatives in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156686"}}